Brian Leber, MDCM, FRCPC – Hematology

Dr. Brian Leber reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Leber is a Clinical Hematologist and Professor of Medicine based at McMaster University Medical Centre and the Juravinski Cancer Centre in Hamilton, Ontario, with an interest…

Brian Leber, MDCM, FRCPC – Hematology

Dr. Brian Leber reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Leber is a Clinical Hematologist and Professor of Medicine based at McMaster University Medical Centre and the Juravinski Cancer Centre in Hamilton, Ontario, with an interest in the pathophysiology of leukemia and investigational new drug trials. He is also a member of the Hamilton Regional Laboratory Medicine Program and the Director of the Molecular Hematology Laboratory in Hamilton.

Education and Training

MD: McGill University Medical School, Montreal, QC, 1981

Internship in Internal Medicine: McGill University Medical School, Montreal, QC, 1981–1984

Residency in Hematology: McMaster University, Hamilton, ON, 1984–1986

Research Fellowship: University of London, Royal Free Hospital School of Medicine, London, England, 1987–1988

Terry Fox Research Fellowship, Molecular Virology and Immunology Program: McMaster University Medical Centre, Hamilton, ON, 1989–1990

Certifications

Internal Medicine, Royal College of Physicians and Surgeons of Canada

Hematology, Royal College of Physicians and Surgeons of Canada

Academic Appointments

McMaster University, Hamilton, ON:

  • Professor, Department of Medicine, Division of Hematology and Thromboembolism, 2007–present
  • Associate Professor, Department of Medicine, Division of Hematology, 1996–present
  • Assistant Professor, Department of Medicine, Division of Hematology, 1990–1996

Financial Disclosure

The final approval of Healthwise content is always made by a clinician with no financial conflicts.

Dr. Leber is on the advisory boards of Novartis Canada, Bristol-Myers-Squibb Canada, and Celgene Canada and is on the review advisory board for Alexion Canada.